High DNA content and prognosis in lymph node positive breast cancer. A case control study by the university of Leiden and ECOG Kennedy W. GilchristRobert GrayDouglas C. Tormey Report Pages: 1 - 8
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients Charlotte R. WengerSusan BeardsleeWilliam L. McGuire Report Pages: 9 - 20
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-Cell Viability Assay Ossi R. KoechliBernd-Uwe SevinHervy E. Averette Report Pages: 21 - 27
Progesterone induction of mammary carcinomas in BALB/c female mice Edith C. KordonAlfredo A. MolinoloClaudia Lanari Report Pages: 29 - 39
A case of intracystic carcinoma of the breast: the importance of measuring carcinoembryonic antigen in aspirated cystic fluid Shigetoshi MatsuoToshifumi EtoTakashi Kanematsu Brief communication Pages: 41 - 44
A new high frequency polymorphism in the HER-2/neu oncogene in normal tissue and breast tumors William T. BriscoeDurwood B. RayR. Michael Williams Brief communication Pages: 45 - 49
DNA flow cytometry and breast cancer David W. Hedley DNA Cytometry Consensus Conference Pages: 51 - 53
Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast David W. HedleyGary M. ClarkDouglas Merkel DNA Cytometry Consensus Conference Pages: 55 - 59
Guidelines for the implementation of clinical DNA cytometry T. Vincent ShankeyPeter S. RabinovitchLeon Wheeless DNA Cytometry Consensus Conference Pages: 61 - 68
Hormones and Breast Cancer, From Biology to the Clinic — Introduction M. Namer Satellite symposium — Ninth International Congress of Endocrinology Pages: 69 - 69